Table 1.
Year | Group | Model | Speciesa | PLN-R14del Effect on SERCA Function | Ref. # |
---|---|---|---|---|---|
2006 | Kranias | Transgenic PLN-R14del mouse | M | SERCA superinhibition when WT-PLN is present. | 2 |
HEK-293 cells | H | SERCA superinhibition when WT-PLN is present. | |||
2012 | Kranias | R14del mouse model in PLN-KO background | M | No SERCA superinhibition in absence of WT-PLN. | 18 |
2012 | Young | Proteoliposomes | H | Partial loss-of-function in presence and absence of WT-PLN. | 28 |
2014 | Middleton | Phospholipid membranes | H | Reduced inhibitory effect on SERCA. | 29 |
2015 | Veglia | DPC-d38 micelles and lipid membranes | H | Loss-of-function mutant (compared to WT-PLN). | 30 |
2021 | Hansen | hiPSC-CMs | H | SERCA function largely unaffected. | 27 |
2021 | Zaza | hiPSC-CMs | H | Loss-of-function. | 24 |
2021 | Bakkers | PLN-R14del zebrafish | Z | Longer Ca2+ transients and slower decay (indicative of enhanced SERCA inhibition). | 25 |
2021 | Kranias | hPLN-R14del mouse | H | Prolonged τ in RV (not LV) cardiomyocytes, indicative of enhanced SERCA inhibition. The propensity to arrhythmia may be increased. | 19 |
2022 | Kranias and Sanoudou | hPLN-R14del mouse | H | Increased binding to SERCA and HAX-1, which may enhance SERCA inhibition (not directly tested). | 42 |
2023 | Kranias and Sadayappan | hPLN-R14del mouse | H | Prolonged τ in RV cardiomyocytes (indicative of enhanced SERCA inhibition). Normal calcium handling in LV cardiomyocytes. | 20 |
2023 | Zaza | PLN-R14Δ/+mouse | M | Loss-of-function. | 23 |
2023 | Silljé | PLN-R14Δ/Δand R14Δ/+mouse | M | Enhanced calcium reuptake. | 5 |
2023 | Robia | HEK-293 cells | H | Loss-of-function via PLN pentamer stabilization and decreased binding affinity for SERCA. | 37 |
Bold represents data indicative of PLN loss-of-function of SERCA inhibition (either partial or complete); italic represents data indicative of SERCA superinhibition.
Ca2+ = calcium; DPC-d38 = dodecylphosphocholine-d38; H = human; HAX-1 = HS-1-associated protein X-1; HEK-293 cells = human embryonic kidney 293 cells; hiPSC-CMs = human induced pluripotent stem cell–derived cardiomyocytes; hPLN-R14del mouse = humanized PLN-R14del mouse model; KO = knockout; LV left ventricle; M = mouse, PLN = phospholamban; PLN-R14Δ/+ mouse = heterozygous PLN-R14del knock-in mouse model; PLN-R14Δ/Δ mouse = homozygous PLN-R14del knock-in mouse model; RV = right ventricle; SERCA = sarco/endoplasmic reticulum calcium adenosine triphosphatase; WT = wild type; Z = zebrafish.
Species column indicates from which species the used PLN-R14del sequence originates.